Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Review and Implication of Act on the Promotion of Korean Medicine and Pharmaceuticals

한의약육성법의 함의 및 발전방향

  • Jeong, Hye In (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Kyeong Han (Department of Preventive Medicine, College of Korean Medicine, Woosuk University) ;
  • Yi, Junhyeok (KM Policy Team, Korea Institute of Oriental Medicine) ;
  • Kim, Daeyoung (General Director of Management Strategy, Korea Institute of Oriental Medicine) ;
  • Sung, Soo-Hyun (Department of Policy Development, National Institute for Korean Medicine Development) ;
  • Lee, Eung-Se (National Institute for Korean Medicine Development)
  • 정혜인 (경희대학교 한의과대학 예방의학교실) ;
  • 김경한 (우석대학교 한의과대학 예방의학교실) ;
  • 이준혁 (한국한의학연구원 정책부) ;
  • 김대영 (한국한의학연구원) ;
  • 성수현 (한국한의약진흥원 정책본부) ;
  • 이응세 (한국한의약진흥원)
  • Received : 2022.08.02
  • Accepted : 2022.08.17
  • Published : 2022.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This study was aimed to review the Act on the Promotion of Korean Medicine and Pharmaceuticals. Method : We searched document about the Act on the Promotion of Korean Medicine and Pharmaceuticals. We used Korean Law Information Center(https://www.law.gov.kr) to find the revision of the act. Results : We looked at the current status of the revision of the Act on the Promotion of Korean Medicine and Pharmaceuticals, and the law was revised four times in total. Through the revision of the law, the definition of Korean medical practice was not only expanded, but also the establishment and role of National Institute of Korean Medicine Development were extended. Specific descriptions of Korean medicine technology will be needed in the future, and laws that are less effective should be revised and the role of National Institute of Korean Medicine Development should be further strengthened. Conclusion : For the future of Korean medicine, in-depth consideration is needed on how to foster oriental medicine.

Keywords

References

  1. The association of korean medicine. Data from the conference on the pharmaceutical affairs law revision committee. Seoul: The association of korean medicine; 1993.
  2. Seoul Korean Medicine Association. white paper on policy of korean medicine 1st edition. Seoul: Seoul Korean Medicine Association; 1990.
  3. The association of korean medicine. white paper on policy of korean medicine. Seoul: The association of korean medicine; 2009.
  4. Lee HW. The Legal Perspectives of the Medical Practice in Korean Medicine. Journal of Society of Preventive Korean Medicine. 2017; 21(2):45-53. https://doi.org/10.25153/spkom.2017.21.2.005
  5. Ku NP, Seol SS. Limits of Innovation in Korean Medicine Industry. Journal of Korea Technology Innovation Society. 2015; 18(4): 667-692.
  6. The Medical Association, "Let's scrap the Korean Medicine and Pharmaceutics Promotion Act". Available at: https://www.medifonews.com/news/article.html?no=167648 (Accessed 2022.07.25.)
  7. World Laws Information Center. Report on the enactment of the Chinese Medicines Act. 2017.
  8. Korea Institute of Oriental Medicine. China's National Chinese Medicine System. 2021.
  9. Kwon SJ, Eom SK. The Concept of Practice of Korean Medicine and the Limitations - Focusing on Legislations and Precedents -. The Journal of Korean Medical History. 2015; 28(1): 121-133. https://doi.org/10.15521/jkmh.2015.28.2.121
  10. Kim SH. Medical malpractice in Korean medicine. Korean Lawyers Association Journal. 2009; 58(6): 358-388. https://doi.org/10.17007/KLAJ.2009.58.6.010010010
  11. Baek KH, Chang YH. A study of Court precedents about concept and nested conditions of the West and East medical treatments. Korean Journal of Medicine and Law. 2014; 22(1): 123-143. https://doi.org/10.17215/kaml.2014.06.22.1.123
  12. Health and Welfare Committee. Partial amendment of Act on the Promotion of Korean Medicine and Pharmaceuticals. 2011.
  13. Health and Welfare Committee. Partial amendment of Act on the Promotion of Korean Medicine and Pharmaceuticals. 2018.